Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)

Trial Profile

Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Vatalanib (Primary) ; Pemetrexed
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 21 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 07 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top